ARC upregulated IL1β in AML cells and increased the levels of CCL2, CCL4, and CXCL12 in MSCs by activating the NFκB pathway, thereby promoting the migration and adhesion of leukemia cells to MSCs. Here, CXCL12 is linked to leukemia.